Short Interest in Aemetis, Inc. (NASDAQ:AMTX) Grows By 10.9%

Aemetis, Inc. (NASDAQ:AMTX) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 6,520,000 shares, an increase of 10.9% from the July 31st total of 5,880,000 shares. Based on an average daily volume of 607,800 shares, the short-interest ratio is presently 10.7 days.

Aemetis Trading Down 1.2 %

NASDAQ:AMTX traded down $0.03 during mid-day trading on Monday, hitting $2.46. 218,500 shares of the company’s stock traded hands, compared to its average volume of 847,129. The firm has a 50 day moving average of $3.00 and a two-hundred day moving average of $3.57. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03. The firm has a market capitalization of $116.11 million, a price-to-earnings ratio of -2.10 and a beta of 1.31.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.25). The company had revenue of $66.56 million during the quarter, compared to analysts’ expectations of $75.37 million. During the same period last year, the firm posted ($0.68) EPS. As a group, equities research analysts expect that Aemetis will post -2.19 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on AMTX shares. Truist Financial reaffirmed a “hold” rating and issued a $3.50 target price (down from $4.00) on shares of Aemetis in a research report on Wednesday, July 31st. StockNews.com upgraded Aemetis to a “sell” rating in a research note on Wednesday, July 31st. HC Wainwright reiterated a “buy” rating and set a $28.00 price target on shares of Aemetis in a research note on Friday, August 2nd. Finally, UBS Group decreased their price target on Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research note on Monday, August 19th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $11.44.

Institutional Trading of Aemetis

Hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new stake in Aemetis during the 1st quarter valued at approximately $60,000. Hutchinson Capital Management CA bought a new stake in shares of Aemetis in the 2nd quarter worth approximately $70,000. State Board of Administration of Florida Retirement System bought a new stake in shares of Aemetis in the 1st quarter worth approximately $84,000. Rhumbline Advisers lifted its position in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in shares of Aemetis in the 2nd quarter worth approximately $306,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.